Masakazu Kakuni
Director/Board Member at PHOENIXBIO CO., LTD.
Profile
Masakazu Kakuni has held the following positions in his career: Director at PhoenixBio Co., Ltd.
since 2005, and President at KMT Hepatech, Inc. since 2020.
Masakazu Kakuni active positions
| Companies | Position | Start |
|---|---|---|
| PHOENIXBIO CO., LTD. | Director/Board Member | 31/05/2014 |
KMT Hepatech, Inc.
 KMT Hepatech, Inc. Miscellaneous Commercial ServicesCommercial Services KMT Hepatech, Inc. provides vivo research services focusing on preclinical development of Hepatitis C, Hepatitis B, and Malaria therapeutics and vaccines. It offers scientific evaluation services for drug metabolism, lipoprotein metabolism, dose response, and drug treatment. The firm provides KMT Mouse, a transgenic mouse model for practical testing of HCV drug candidates. The company was founded by Norman Miles Kneteman, David F. Mercer and David Lorne John Tyrrell in 2001 and is headquartered in Edmonton, Canada. | President | 30/11/2020 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHOENIXBIO CO., LTD. | Commercial Services |
| Private companies | 1 |
|---|---|
KMT Hepatech, Inc.
KMT Hepatech, Inc. Miscellaneous Commercial ServicesCommercial Services KMT Hepatech, Inc. provides vivo research services focusing on preclinical development of Hepatitis C, Hepatitis B, and Malaria therapeutics and vaccines. It offers scientific evaluation services for drug metabolism, lipoprotein metabolism, dose response, and drug treatment. The firm provides KMT Mouse, a transgenic mouse model for practical testing of HCV drug candidates. The company was founded by Norman Miles Kneteman, David F. Mercer and David Lorne John Tyrrell in 2001 and is headquartered in Edmonton, Canada. | Commercial Services |
- Stock Market
- Insiders
- Masakazu Kakuni
